Contribution of Beta-HPV Infection and UV-Damage to Rapid-onset Cutaneous Squamous Cell Carcinoma during BRAF-inhibition Therapy

PURPOSE: BRAF-inhibition (BRAFi) therapy for advanced melanoma carries a high rate of secondary cutaneous squamous cell carcinoma (cSCC) and risk of other cancers. Ultraviolet (UV) radiation and α-genus human papillomavirus (HPV) are highly associated with SCC, but a novel role for β-genus HPV is su...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Cancer Res
Egile Nagusiak: Cohen, Daniel N., Lawson, Steven K., Shaver, Aaron C., Du, Liping, Nguyen, Harrison P., He, Qin, Johnson, Douglas B., Lumbang, Wilfred A., Moody, Brent R., Prescott, James L., Chandra, Pranil K., Boyd, Alan S., Zwerner, Jeffrey P., Robbins, Jason B., Tyring, Stephen K., Rady, Peter L., Chappell, James D., Shyr, Yu, Infante, Jeffrey R., Sosman, Jeffrey A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452444/
https://ncbi.nlm.nih.gov/pubmed/25724524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2667
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak